Literature DB >> 23429399

Detection of local tumor progression by (18)F-FDG PET/CT following lung radiofrequency ablation: PET versus CT.

Naohisa Suzawa1, Koichiro Yamakado, Motoshi Takao, Osamu Taguchi, Tomomi Yamada, Kan Takeda.   

Abstract

OBJECTIVE: The objective of this study was to compare the diagnostic performance for detecting local tumor progression between FDG PET and CT in patients who received lung radiofrequency (RF) ablation for the treatment of malignant lung tumors.
METHODS: A total of 469 FDG PET/CT studies were performed at 4 time points (3, 6, 9, 12 months) after lung RF ablation in 143 patients (87 male and 56 female patients) with 231 tumors. The SUVmax was calculated in treated tumors in each PET image. The percentage decrease (% decrease) in ablative zone size was evaluated in each CT image. The final response was judged based on follow-up findings and histology. Diagnostic performance of FDG PET and CT images was evaluated using receiver operating characteristic analysis.
RESULTS: Local tumor progression was identified in 37 patients (25.9%, 37/143) having 47 tumors (20.4%, 47/231) during the median follow-up of 24 months (range, 8-75 months). The area under the receiver operating characteristic curve of PET was higher than that of CT at all 4 time points (0.71 vs 0.55 at 3 months, 0.82 vs 0.60 at 6 months, 0.84 vs 0.66 at 9 months, and 0.92 vs 0.68 at 12 months), and its diagnostic performance was significant at each time point (P = 0.0010 at 3 months and P < 0.001 at 6, 9, and 12 months). However, the area under the receiver operating characteristic curve of CT was significant at 9 months (P = 0.040) and 12 months (P = 0.032).
CONCLUSIONS: FDG PET/CT is better able to assess local tumor progression at 3 and 6 months after lung RF ablation than CT alone.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23429399     DOI: 10.1097/RLU.0b013e31828166f6

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN: 0363-9762            Impact factor:   7.794


  3 in total

1.  Diagnostic accuracy of 18F-FDG PET/CT for assessing response to radiofrequency ablation treatment in lung metastases: a multicentre prospective study.

Authors:  Françoise Bonichon; Jean Palussière; Yann Godbert; Marina Pulido; Edouard Descat; Anne Devillers; Catherine Meunier; Sophie Leboulleux; Thierry de Baère; Claire Galy-Lacour; Laurent Lagoarde-Segot; Anne-Laure Cazeau
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-09-17       Impact factor: 9.236

Review 2.  The Role of PET Imaging Before, During, and After Percutaneous Hepatic and Pulmonary Tumor Ablation.

Authors:  Eric D McLoney; Ari J Isaacson; Patrick Keating
Journal:  Semin Intervent Radiol       Date:  2014-06       Impact factor: 1.513

3.  18F-FDG PET/CT performed immediately after percutaneous ablation to evaluate outcomes of the procedure: preliminary results.

Authors:  Juliana Romanato; Marcos Roberto Menezes; Allan de Oliveira Santos; Regis Otaviano Franca Bezerra; Mariana Cunha Lopes Lima; Elba Etchebehere
Journal:  Radiol Bras       Date:  2019 Jan-Feb
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.